NEW YORK (GenomeWeb News) – South Korean genomics-based biotech firm DNA Link has signed a Powered by Affymetrix Program agreement providing it a worldwide license to develop and commercialize a forensic test using Affy's microarray technology and the South Korea FDA-cleared GeneChip System 300Dx v.2, Affy announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.